FDA approves groundbreaking sickle cell cures

In a landmark decision, the Food and Drug Administration on Friday, Dec 8, approved two gene therapies for anyone 12 and older suffering from the most severe form of sickle cell disease, a brutal blood disorder that has long been neglected by medical research. The decisions are being hailed as milestones for treating sickle cell and … Continue reading FDA approves groundbreaking sickle cell cures